Picturing the Brain Inside, Revealing the Illness Outside: A Comparison of Different Meanings Attributed to Brain Scans by Scientists and Patients by Cohn, S
Walter, FM; Humphrys, E; Tso, S; Johnson, M; Cohn, S (2010) Pa-
tient understanding of moles and skin cancer, and factors inﬂuencing
presentation in primary care: a qualitative study. BMC Fam Pract,
11. p. 62. ISSN 1471-2296
Downloaded from: http://researchonline.lshtm.ac.uk/1606976/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/RESEARCH ARTICLE Open Access
Patient understanding of moles and skin cancer,
and factors influencing presentation in primary
care: a qualitative study
Fiona M Walter
1,2*, Elka Humphrys
1, Simon Tso
3, Margaret Johnson
4, Simon Cohn
1
Abstract
Background: Melanoma incidence in the UK has doubled over two decades, yet there is conflicting evidence
about factors which prompt or delay patients seeking advice. Aim: To explore patient understanding of pigmented
skin lesions (moles) and skin cancer, and factors which influence seeking help in primary care.
Method: Semi-structured interviews with forty MoleMate Trial participants, analysed using the theoretical
framework of the Safer-Andersen model of Total Patient Delay.
Results: Patient understanding and awareness was influenced by personal, family and friends’ experiences of
moles, skin cancer and other cancers, knowledge of risk factors, and the lay media. The route to consulting was
complex and often iterative. For lesions that people could see, detecting and appraising change was influenced by
comparisons with a normal mole on themselves, a family member, friend or image. Inferring illness came about
with recognition of changes (particularly size) as serious, and associated ‘internal’ symptoms such as pain. For
lesions that people could not see, family, friends and health professionals detected and appraised changes.
Deciding to seek help was often prompted by another person or triggered by rapid or multiple changes in a mole.
Three of four people subsequently diagnosed with melanoma did not seek help; instead, their GP opportunistically
noticed the lesion.
Conclusions: Changing moles are often perceived as trivial and not signifying possible skin cancer. This study
contributes to current national strategies to improve patient awareness and earlier diagnosis of cancer by
highlighting factors that can trigger or act as barriers to seeking help.
(ISRCTN79932379)
Background
Malignant melanoma is the major cause of death from
skin cancer in the UK. Over the last twenty years the
incidence has more than doubled, with 9,500 new cases
and 1,800 deaths in 2006 in England and Wales (age
standardised incidence 13.7/100,000 people). The most
important prognostic feature for patients with melanoma
is the thickness of the primary tumour at diagnosis
(thickness of 1 mm or less at diagnosis- 95% disease free
after 5 years; thickness of 3 mm or more at diagnosis-
60% disease free after 5 years) [1]. Although the National
Institute for Health and Clinical Excellence guidelines on
skin cancer [2] and the recent National Awareness and
Early Diagnosis Initiative for Cancer (Department of
Health and Cancer Research UK, November 2008) advo-
cate the raising of public awareness of symptoms and
encouragement of people to seek help early, there is con-
flicting evidence about the impact of this on time from
symptom awareness to presentation in primary care, and
the thickness of the lesion at diagnosis [3,4]. However, it
is likely that a shorter time from awareness to diagnosis
will reduce psychological distress and may increase the
proportion of thinner melanomas [5].
While patients frequently present to their general
practitioners (GPs) with concerns about moles or other
pigmented skin lesions, few will be diagnosed as mela-
noma: even among higher risk groups such as men aged
over 60 years, less than 1 in 33,000 moles are estimated
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vus, is extremely common, with most people having
between 5 and 20 moles which may vary in size, shape
and colour. Moles may be congenital, but usually appear
during childhood, and an increase in number is asso-
ciated with age, fair skin and sunlight exposure. Patients
need to be able to distinguish these ‘normal’ changes
from ‘abnormal’ changes in size, shape or colour, which
may indicate melanoma, in order to make the decision
to seek help from their GP.
There is a growing literature concerning seeking help
for cancer symptoms, as the time from symptom detec-
tion to presentation in primary care (known as ‘patient
delay’), and the time from presentation in primary care
to referral to secondary care (known as ‘primary care
delay’) are likely to be key determinants of patient out-
comes for melanoma and other cancers [7]. A systema-
tic review of patient delays in presenting with cancer
symptoms suggested that fear of embarrassment (that
the symptoms were trivial or affected a sensitive body
area) or fear of cancer (pain, suffering and death) are
major contributors to delay in diagnosis [8]. Older age,
non-disclosure of symptoms, living alone, and negative
attitudes towards the GP, can also influence delays in
symptom presentation for breast cancer [9]. Misinter-
pretation of symptoms is another important factor con-
tributing to patient delay in presenting with symptoms
of upper gastro-intestinal [10], colorectal [11], and oral
[12] cancer symptoms.
It is currently unknown how much these factors, or
patient understanding of moles, influence seeking help
for symptoms of skin cancer although factors which
influence delay in the diagnosis of melanoma have been
studied. There are other studies which suggest the utility
of investigating these patient factors [13,14], however,
most have used quantitative, retrospective methods of
data collection from secondary care cohorts of people
diagnosed with melanoma which limit the generalisibil-
ity of their findings to primary care populations with
benign lesions as well as skin cancer. We therefore con-
ducted interviews with the aim of exploring how patient
understanding and evaluation of their moles influenced
their decision to consult in primary care.
Methods
Semi-structured telephone interviews were conducted
between April and August 2008 with people who had
been recruited to the feasibility phase of the MoleMate™
UK Trial. This randomised controlled trial
(ISRCTN79932379, Cambridgeshire REC approval 07/
H0308/167, approval also covered telephone interviews),
funded by the National Institute of Health Research’s
School for Primary Care Research, aims to test whether
using the MoleMate™ system (a novel device combining
a diagnostic algorithm developed for general practice
with SIAscopy, a multispectral skin imaging technique)
will improve the effectiveness of management of suspi-
cious pigmented lesions in primary care. For the trial, a
‘suspicious pigmented lesion’ is defined as any pigmen-
ted lesion presented by a patient, or opportunistically
seen by a clinician, which cannot immediately be diag-
nosed as benign and the patient reassured.
The trial’s pilot phase was set in 3 general practices in
Cambridgeshire, and lasted 4 months. The entry criteria
were patients aged 18 and over, presenting to their GP
or practice nurse with a mole or other pigmented skin
lesion which was not immediately diagnosed as benign.
The only exclusion criterion was people considered by
their GP to be unsuitable due to other on-going physical
or psychological conditions. Ninety participants were
recruited and, after completing their pilot trial consulta-
tion, all participants were then invited to be interviewed.
Participants were interviewed within one month of their
trial consultation and asked to reflect on the steps
which led towards their presentation in primary care.
A flexible interview guide was used to ensure consistency
across the interviews, while allowing interviewees to
express their ideas, understanding and concerns freely.
This guide contained questions about knowledge of skin
cancer and its risk factors, the circumstances leading to
consultation, and the process of the consultation itself:
Why did you go to see your Doctor or Practice Nurse
initially?
When did you (or another person) first notice your
mole (the changes in your mole)? What did you
notice?
What were your thoughts about the mole (the
changes in your mole)?
What was different about it (compared to other
moles)?
What explanation did you have for the changes?
What made you decide to see a health professional?
Did you talk with anyone else about your mole
(changes in your mole)?
Did you think it could be serious?
Was your decision to consult the health professional
influenced by anyone else?
How would you feel going back to your Doctor about
other moles?
Could you tell me what you know about skin cancer?
What causes do you know of? Where have you
learned this?
We selected a convenience sampling strategy and the
first 40 people to agree were interviewed: the data were
then judged sufficient to reach saturation of the main
themes. All participants were interviewed over the
Walter et al. BMC Family Practice 2010, 11:62
http://www.biomedcentral.com/1471-2296/11/62
Page 2 of 10telephone by one of the authors (EH). The interviews
lasted up to 25 minutes and were audio-taped and fully
transcribed.
In order to gain an overall appreciation of the inter-
viewees’ understanding, each transcript was read and
reread by 2 authors (EH, FW), and this process of read-
ing and comparison was used to identify themes [15].
About half of the transcripts were also read by the other
members of the research team so that the analysis could
be interpreted and refined though regular discussions.
At this stage we incorporated the theoretical perspective
of Safer and colleagues [16], modified by Andersen and
colleagues in their model of Total Patient Delay [17],
which gives detailed stages of a patient’sp a t h w a yf r o m
awareness of a symptom to diagnosis and treatment.
The model identifies ‘appraisal, illness, behavioural,
scheduling and treatment delays’ referring to the time
between a patient first detecting change, appraising
change, inferring illness, deciding to consult, visiting pri-
mary care, and referral, diagnosis and commencement of
treatment (see Figure 1).
We used the model’s key stages as a framework to
structure our coding, although we omitted consideration
of referral, diagnosis and commencement of treatment
issues as these were beyond the scope of this study.
Transcripts were coded using the software package
NVivo and five transcripts were independently coded by
EH (a science graduate) and FW (a GP) who then
further refined the coding frame with discussions about
areas of disagreement and consensus. Data were then
analysed using the widely used Framework approach
[18]. Comparisons were made within interviews and
across interviews to identify both patterns of themes
and deviant cases. The quotations that follow were cho-
sen to reflect a range of both consensual and dissenting
views, and they are accompanied by the patient’s study
identification number, gender, age and educational level
(EL1 = no qualifications; EL2 = GCSE or similar; EL3 =
A Level or similar; EL4 = higher education or similar;
EL5 = degree or similar). * denotes subsequent diagnosis
of melanoma.
Results
See Table 1 for characteristics of participants interviewed.
The route to seeking advice about a mole or help with
concerns about skin cancer symptoms was often com-
plex and iterative. Some people seemed to have a clear
idea of risk factors and symptoms of skin cancer, and
for them the recognition of one of these prompted a
decision to seek help. More people seemed much less
well informed about changes in moles and possible
symptoms of skin cancer. Using the framework of the
Safer-Andersen model, we have characterised the factors
influencing patient understanding and presentation in
primary care as follows: pre-existing awareness, detect-
ing and appraising change, inferring illness, and deciding
to seek help.
1 Patient understanding
1.1 Pre-existing awareness
In accounts of their pre-symptom experiences, people
described knowledge of changes in shape, size and col-
our of a mole as possible skin cancer symptoms. Some
also mentioned other symptoms such as oozing, bleed-
ing and irritation. Only a minority appeared to apply
this knowledge to themselves, as few linked changes in
their own moles with skin cancer or the need for
Figure 1 The Model of Total Patient Delay, after Safer [16]and
Andersen [17].
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Page 3 of 10potential symptoms of melanoma to be seen and treated
promptly.
[Melanomas can] change in size, they itch... they
change colour, they change shape, they can bleed and
crack and just start doing things that they never did
before. [ID16: F, 61, EL1]
Certain types of moles can create problems and if not
nipped in the bud could spread nastily, that sort of
thing. [ID06: M, 67, EL5]
Most people were aware of sun exposure as a risk fac-
tor for skin cancer and some also mentioned the risk of
sunburn, particularly as a child. Other risk factors such
as skin types, sun bed use, and family history were dis-
cussed less often. Nevertheless, people who did mention
family history as a risk factor appeared to be alert to
changes in their own moles, and the possible signifi-
cance of such changes.
W e l lIw o r r ya b o u ts k i nc a n c e r sb e c a u s ei t ’si nt h e
family, there’s lots of cancer in the family and there has
been some skin cancers, so I do worry about that. [ID28:
F, 38, EL3]
Personal meaning was given to people’sk n o w l e d g e
about moles and skin cancer by their experiences not
only with their own moles, but also those of significant
others such as family members and friends. Most people
felt that personal past experiences both heightened their
awareness of new changes in their own moles, and
‘allowed’ them to seek further help. A few related that
their past personal experiences, or the experiences of
family or friends, made them feel much more vulnerable
to skin cancer. Several people mentioned being a ‘moley’
person, or belonging to a ‘moley family’, but this did not
seem directly linked to either feeling particularly pro-
tected from, or particularly vulnerable to, skin cancer.
It then makes you more aware of the other moles, so...
there’s a terrible tendency to become slightly hypochon-
driac about it and think “hang on a minute, I think this
other one looks a bit dodgy now”. [ID09: M, 60, EL5]
I’ve had a few friends who’ve had cancerous moles
removed...so that makes you a little bit more aware that
people of your age group can have it. [ID24: F, 30, EL5]
We are a ‘moley’ family- I have two on my stomach to
the right of my umbilicus and my daughter has some in
the same place and even my mother-in-law (laughs)
which is a bit bizarre, and my mother. [ID15: F, 61, EL5]
The impact of health promotional literature appeared
to be limited, and many people were unaware of skin
cancer preventive messages concerning use of suncream
and sunbeds. One woman mentioned that the wording
of a health promotional leaflet had more impact than
the photographs which she felt did not resemble her
own mole. In contrast, the impact of information from
the non-medical media appeared to be more influential:
people recalled reading about celebrities having skin
cancer and newspaper articles about sun risks.
I had picked up a leaflet in the local chemist and that
did have pictures and diagrams about moles and when
you should consult somebody...mine didn’t look anything
like the ones that were in the pictures, but in the descrip-
tions it was talking about irregular [shapes] and bleeding
and...it was those two elements that I picked up on.
[ID22: F, 41, EL5]
I remember before I made the appointment I was read-
ing something on John McCain, the US presidential can-
didate who has had skin cancer as well, and that article
in the magazine made me make the appointment. [ID40:
F, 40, EL5]
1.2 Detecting and appraising change
Most people seemed to hold some kind of an idea, or a
mental model, of a ‘normal’ mole. When a particular
mole was visible to them, people detected changes in
the size, colour or shape, and became aware that one
was different: this generally led to an appraisal of
Table 1 Characteristics of participants interviewed (n = 40)
Number or
range
Age
Mean 57 *
Range 22 - 83
Gender
Female 25
Male 15
Ethnic origin
White British 39
Chinese 1
Employment status
Employed 18
Looking after home/family 1
Retired 17
Unknown 4
Education level
No qualifications (EL1), GCSE (EL2), A Level
(EL3)
17
Higher education (EL4), Degree (EL5) 21
Unknown 2
Referral status
Not referred 24
Referred 16
Reassured 5
Biopsied and benign 7
Melanoma 4
* Mean age: Female 53, Male 63
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people appraised these changes by making comparisons
with other ‘normal’ m o l e so nt h e i ro w nb o d y .S o m e
people also compared their moles with the moles of
other family members or friends, and a few people used
health promotional literature or the non-medical media.
Some people also appraised a change in their mole
against their awareness of risk factors for skin cancer.
This one is not an ordinary mole, it’s not like the other
moles I’ve got. [ID04: F, 52, EL3]
It just sort of struck me one day that it was darker
than it used to be, that it was suddenly noticeable where
it hadn’t been previously. [ID26: M, 22, EL5]
The others don’t bother me in the way that this one
did because they just look like all the others, you know,
perfectly round and brown and harmless.... I was con-
cerned because it was raised, and it was also very dark
and didn’t seem to look like any other moles that I’d got.
[ID31: F, 52, EL5]
Ih a d n ’t spotted it there before...and because it’so nm y
shoulder and I quite often get sunburn on my shoulders,
you know, I sort of figured it might be an idea to check it
out. [ID24: F, 30, EL5]
However, about half the interviewees had a lesion on
an area of their body which was not easily visible to
them, thus making it difficult to detect change. These
people reported that their mole had been first noticed
by another person, usually their partner or close family
relative, and sometimes by a health professional.
My wife told me that my mole on my abdomen had
enlarged since she last saw it....well, you know how it is,
you don’t notice it for years on end and then I had no idea
whether it’s got bigger or not really. [ID06: M, 67, EL5]
[The consultation] was about this knee actually... I
took my trousers off and this doctor came in and he
called this other doctor in, and she said straightaway
“How long have you had that mole?” [ID19*: F, 79, EL1]
2 Presentation in primary care
2.1 Inferring illness
About half the interviewees denied any concern about
their moles and had not considered that the mole might
signify an illness, either serious or trivial. These people
had been persuaded to seek help by concerned partners
or other family members, or had had a lesion noticed by
a health professional during a consultation for another
reason.
Well funny enough, my son, he’s only seven actually,
and he’d mentioned it a couple of times “are you going
to go and see the doctor with your mole?” and that’s
really what made me go in the end. [ID12*: M, 61, EL3]
Among those who could see their own mole and had
detected changes, people took a variable amount of time
to appraise these changes and only some inferred illness.
All interviewees discussed the implication of the size of
their mole: the sizes mentioned ranged from ‘tiny’ to
‘very small’ to ‘getting bigger’. A small size usually indi-
cated a lack of seriousness, while an increase in size or
changing shape seemed to indicate the potential for a
more serious diagnosis. In particular, a combination of
two or more changing symptoms contributed to the
inference of illness and the decision to seek help. How-
ever, several people became concerned about the ser-
iousness of the symptoms despite the mole continuing
to have a ‘small size’ with no associated changes.
It’s not a big thing, it’s very small... I can hardly notice
it, and I’ve looked in the mirror, I can see it but it’s only
like a little pinball. It’s not big...that’sw h yI ’mn o tt o o
worried. [ID23: M, 79, EL1]
The one on my chest ... [is] the biggest, you know it’s
bigger than anything else I’ve got and it’sq u i t er e di n
colour so it did concern me. [ID18: F, 44, EL5]
A few people mentioned symptoms other than visible
or external symptoms. These ‘internal’ symptoms, such
as lumps or pain, appeared to signify a more worrying
bodily change with suggestions of ‘invasion’.A sp e o p l e
appraised the changes in their mole, an ‘internal’ symp-
tom seemed to add gravity, and one elderly man
described his lack of concern when noticing a mole get-
ting bigger on his face as due to the fact that there was
not also a lump:
I’ve had it for years really, the mark in the middle of
my forehead....It’s actually got bigger itself on the fore-
head but it’s still flat, it’s not like a big lump or anything
like that. [Lesion identified by Health Professional]
[ID07*: M, 83, EL unknown]
I’ve had this mark on my leg for years...and just
recently, within the last three or four months, it has
started to pull, so the mark is on the, upper surface of
m yt h i g h ,a n di tf e e l sa si fi t ’s pulling down into the
knee. [ID15: F, 61, EL5]
Generally, there was a lack of connection between
moles and skin cancer: among the people who had
detected changes in their moles, many did not recognise
the changes as possible symptoms of skin cancer. Con-
versely, there were many who did recognise possible
symptoms of skin cancer, yet most did not seem to fear
a ‘serious’ diagnosis.
Id o n ’t quite understand...why a mole should then sig-
nify that you’ve got cancer or something like that, you
know. Why is that? [ID12*: M, 61, EL3]
Well [it’s] nothing really to worry about is it?...it’sj u s t
a simple mole...I don’t think that sort of cancer is life
threatening..I mean...surely if that was going to kill me it
would have done it by now...It’sn o tab i gt h i n g . . . .H e
noticed this mole and he said it looked cancerous...I
don’t really know anything about it.. It’sj u s tam o l ea s
far as I’m concerned. [ID23: M, 79, EL1]
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didn’t want to think it was serious. But there’sa l w a y sa
niggling question over these things. [ID18: F, 44, EL5]
2.2 Deciding to seek help
Most participants who could see a change in their mole
monitored and appraised it over a period of time ran-
ging from a few weeks to several years before deciding
to seek help. Rapid or multiple changes prompted peo-
ple to seek help sooner, while gradual or ‘steady’ change
did not prompt people to seek help.
After about 3 months [I thought] maybe I ought to do
something about it and then after a period of another
w e e ko r2Id e c i d e dt om a k ea na p p o i n t m e n t . . .i tw a s
getting slightly bigger and slightly darker all the time ...
it’s gone from nothing at all ...so gradually it was getting
more prominent. [ID09: M, 60, EL5]
It h i n kI ’d caught it early enough on, so that if it did
prove to be something nasty then I’d hope that I was in
plenty of time for it to be removed. ID28: F, 38, EL3]
Deciding to seek help also depended on access to pri-
mary care professionals: while some people felt access
was readily available, others had concerns about
encounters with primary care professionals. We identi-
fied three issues which seemed specific to people seek-
ing help for their moles.
First, some people expressed the need to have their
concerns ‘taken seriously’.T h e ym e n t i o n e dar a n g eo f
factors which might lead to not being taken seriously,
including being considered to have wasted their doctor’s
time, or consulted with trivial symptoms or unnecessary
worries.
In my opinion the medical profession has a tendency to
think, If [the reason] is not important, why should people
be worrying about it. Well you know, anybody’s worry is
very significant to them even if it’s totally unfounded.
[ID09: M, 60, EL5]
I brought up the issue of there being lots of cancers in
my family and I feel at that point then it was taken a
little bit more seriously. [ID28: F, 38, EL3]
Second, many people felt they needed to justify (either
to themselves or the GP) their decision to see their doc-
tor, particularly if the mole was small. Some felt that
monitoring their lesion over time provided enough justi-
fication, while others needed to accumulate more than
one reason to consult:
Il e f ti tac o u p l eo fw e e k sa n dIj u s tt h o u g h tw e l l ,y o u
know, I’ve got to be sensible about this, rather than wast-
ing doctor’s time, I just thought it was something I
should follow up on. [ID34: F, 54, EL2]
It would have been several weeks, it might have been
even a couple of months...and I think when I went to see
him I actually went about something else as well...Well
b yt h et i m eI ’d accumulated two or three things, I felt
justified to visit. [ID31: F, 52, EL5]
Third, people also often needed to have a catalyst or
trigger to seek help: this could include noticing a new
change in the lesion or a combination of symptoms, or
perhaps an observation made by a family member or
friend.
I had one on my tummy, probably about 5 months
ago, and I kept thinking “Im u s tg oa n dt a l kt ot h ed o c -
tor about that, I must go and talk to the doctor about
them”. And then I found another one just sort of between
my armpit and the side of my breast and then when I
noticed that, and when it bled I went and saw the doctor
... about a week and a half later. [ID22: F, 41, EL5]
Ik n e wIh a dt h i sm o l eo nt h eb a c ko fm ya r m . . . A n d
people said oh you ought to get that checked out and I
kept forgetting. And I work...at [the hospital]...and one of
the nurses said have you had that checked out, so I
made an appointment to go the doctors and I asked her
to have a look at it. [ID36: F, 46, EL4]
3 Factors influencing presentation in primary care with
melanoma
Four interviewees went on to have melanoma diagnosed
and treated. The patient characteristics and accounts of
their pre-presentation experiences were compared with
the characteristics and accounts of those diagnosed with
benign lesions.
All four people with a subsequent melanoma diagnosis
were older than the mean age (83, 83, 79 and 61), and
three were male. They had a range of educational levels,
from no qualifications to a degree.
Table 2 highlights factors in the four interviewees’
accounts of their pre-presentation experiences. All gave
some indication of a pre-existing awareness of skin can-
cer symptoms and the risks of sun exposure. Three had
either lived in tropical climates as a child or adult, or
had an above-average exposure to sunlight due to their
occupation. Two gave accounts of friends or family
members undergoing recent treatment for skin cancer,
and one recounted a personal experience of mole
removal in the past. All had been aware of their pig-
mented skin lesion for a long while, ranging from
months to years. Two had noticed changes in either size
or colour, and one recollected, with his partner, compar-
ing the changing mole with a description in a paper and
both concluding that the changes were not serious.
None admitted to inferring illness or having any con-
cerns that the changes could be serious. One felt that
this was because the lesion was flat rather than lumpy,
and one gave a range of reasons including that the
lesion was not easily visible, that he was not systemically
unwell, and that his business commitments were more
important than an appointment with his doctor. Despite
all having some pre-existing awareness of moles and
skin cancer, and most having detected changes in their
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incidentally noticed by their doctor during a consulta-
tion for another ailment rather than deciding to seek
help. The fourth had been persuaded to seek help by his
worried young son.
Discussion
Our data illuminate patient understanding of moles and
skin cancer, as well as the stages people go through
from noticing a change in a mole to presenting in pri-
mary care with a suspicious pigmented skin lesion. Key
findings include: the important role that personal, family
and friends’ experiences of moles and skin cancer can
take in informing not only knowledge and understand-
ing but also the appraisal of lesions and seeking help;
using comparisons with moles on self, other people or
pictures to assess changes; the role of family, friends
and health professionals to detect and appraise changes
i nl e s sv i s i b l el e s i o n s ;a n dt h er o l eo fm u l t i p l es y m p -
toms, a lump, or pain, in heralding seriousness. It is
noteworthy that up to half of the interviewees said they
were not concerned about their moles. We presented
the four patients subsequently diagnosed with mela-
noma as case studies to illustrate that, despite national
health promotion strategies such as SunSmart, these
people did not recognise melanoma symptoms or associ-
ate risk factors such as excessive sun exposure with
themselves.
Strengths and weaknesses of the study
The two key strengths of this qualitative study are that
it addresses an important clinical area where the
evidence base is weak, and it applies a theoretical model
to underpin the analysis. Other methodological
strengths included the size of the sample, and that four
of these forty participants went on to have melanomas
diagnosed.
While we acknowledge that data are drawn only from
people who were recruited to the MoleMate™ UK Trial
a n dt h a tt h eg r e a t e rm a j o r i t yo ft h e s ep e o p l eh a da
benign lesion with only a small minority subsequently
diagnosed with melanoma, these interviews with trial
participants, conducted as soon after their trial consulta-
tion as possible, achieved fresh accounts of the pre-pre-
sentation and diagnostic period. Other studies have
reported retrospective narrative interviews [19-21]: these
have mainly been conducteds o m et i m ea f t e rt h ed i a g -
nosis of melanoma and the accounts may not accurately
relate what really happened as they rely on people’s
recall of events [22]. This qualitative study aimed to
describe a range of patient views rather than numerical
representation and generalisibility. We therefore
included people with a wide range of experiences and
background. Ethnic variation was limited, reflecting the
geographical region in which the study was carried out.
We acknowledge that the interviews were brief, and sug-
gest this was due to the practical issue of using tele-
phone rather than face to face interviews. Face to face
interviews might have allowed the exploration of peo-
ples’ understanding and experiences in more detail, but
this approach did not appear to compromise the quality
of the data. We also acknowledge the limitation of
recruiting from only 3 practices in Cambridgeshire:
while this limits the generalisibity of the findings, we
Table 2 Factors affecting presentation of people subsequently diagnosed with melanoma to their GP
Pre-existing awareness Detecting and appraising change Inferring illness Deciding to seek help
Patient
ID 5
[M, 83, EL
5]
*Grew up in hot climate and
over-exposed to sunlight
*Several moles removed some
years ago
*Friend and daughter recently
treated for skin cancer
*Aware of mole for about 2 years *’I thought it was
something else’
*Noticed by GP
*Felt ‘alarm, and relieved that it
had been noticed’.
Patient
ID 7
[M, 83, EL
unknown]
*Worked outdoors ‘all adult life,
often with shirt off, which I
regret now’
*Many black moles on back
*Aware of mole in middle of forehead for
‘a long while’‘ had it for years’
*New black mark in centre
*’Its got bigger’
*’I kept thinking it
was a birthmark’
*It’s still flat, not a
lump’
*Noticed by GP
Patient
ID 12
[M, 61,
EL3]
*Aware of danger of sun
damage
*Friend recently treated for skin
cancer on face
*Aware of mole going darker ‘months
ago’
*Compared mole with description of
melanoma in paper but he and partner
felt not similar
*Not easily visible
so not concerned
*Competing
demands of self
employment
*Able to play golf
so ‘How can I be
ill?’
*Young son suggested visit to
doctor ‘a couple of times’ before
made appointment
Patient
ID 19
[F, 79, EL
1]
*Lived in tropics for many years
as adult
*Wears suncream to play golf
*Noticed adjacent mole which is ‘bigger
and darker’ about 1 year ago
*Noticed by GP
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It may be that understanding of moles, skin cancer and
seeking help may vary across the UK, countries, and
health service systems.
Using the theoretical Model of Total Patient Delay
Our findings suggest that the stages are not always
passed through successively and independently as sug-
gested by Andersen et al., but that the stages can be
merged or omitted altogether (for example, one partici-
pants subsequently diagnosed with melanoma was aware
of changes in his mole, but had decided not to seek
help as he did not feel unwell). This suggests that while
the model provides a useful description of the process,
the stages do not necessarily exist in the mind of many
patients, with important implications for research which
aims to use the stages of the model to determine the
interval lengths from symptom awareness to diagnosis.
We have also highlighted novel themes such as a pre-
existing awareness of moles and risk factors for skin
cancer. We tentatively suggest that the model, which
currently includes appraisal, illness, behavioural and
scheduling delay intervals, could be expanded to include
the stage prior to the appearance of symptoms, and
could also be broadened to include the significant role
of others. We are also concerned that the model implies
that all individuals are ‘delayers’,a st h i st e r mi sv a l u e -
laden and may imply negative outcomes and fault. In
reality, patients are frequently involved in a variety of
judgements and reflections prior to seeking attention
that do not correspond with a simple description of bar-
riers or promoters for seeking help. We would therefore
suggest replacing ‘delay’ with ‘time to presentation’
wherever possible.
Clinical implications
Diagnosing melanoma is a challenge in primary care
[23] as people present frequently with moles and other
pigmented lesions, yet the incidence of melanoma is
low: a GP may diagnose melanoma in only one patient
every three to five years. In our study three of the four
subsequently diagnosed melanomas were opportunisti-
cally noticed by the GP during a consultation for
another problem, a higher proportion than in other stu-
dies which suggest the majority of melanomas are self-
discovered [24]. Despite this, many people mentioned
the GP as a barrier to seeking help. Similar views have
been expressed in other studies of people with cancer
[25], and are important as experts have questioned
whether the ‘GP as gatekeeper’ model of health care has
contributed to lower cancer survival rates found in the
UK compared with other Western European countries
[26]. To overcome this potential barrier, GPs can encou-
rage people to mention all their concerns at the
beginning of a consultation, and then triage the list
according to the level of concern of both patient and
doctor. Internet-based diagnostic tools such as self
assessment algorithms may provide more means for
patients to overcome these barriers in the future.
The findings from the study also have implications for
patients, as the participants frequently did not consider
their changing mole to be symptomatic of melanoma.
This may be due to the perceived trivial nature of the
symptoms: people with cancer of the skin, mouth and
cervix have been found to be less likely than those with
breast cancer to seek help [27]. Some participants misat-
tributed changes in pigmented lesions when visible, or
were unaware of changes when not easily visible to
themselves. A UK primary care population has been
shown to be more concerned about bleeding, oozing
and crusting as symptoms of melanoma, rather than
changes in shape or colour in pre-existing moles [28],
compared with a similar Aust r a l i a np o p u l a t i o nw h o
were better informed about the importance of change in
a pre-existing lesion [29]. Lay understanding may also
vary between genders, ages, ethnic groups and educa-
tional levels [30]. The importance of other people along
the patient’s pathway towards seeking help was also
highlighted in this study. Whilst on some occasions the
importance of relatives or friends was pragmatic, for
example to see a mole on the back that a patient
couldn’t see themselves, more generally it was through
the dialogue with others that previous experiences and
alternative perceptions of the mole and its possible
changes were discussed, and led people to finally seek
help.
Finally, the study has implications for public health
strategies such as SunSmart, as many participants were
unaware of sensible sun-exposure behaviours, and edu-
cational strategies to promote skin awareness, self-exam-
ination and timely consultation. Our data suggests
several key areas which are important for future
research, and likely to provide significant resources for
successful health promotion. First, we need to create a
stronger link between people’sm e n t a lm o d e l so fm o l e s
and melanoma for effective symptom appraisal. Health
promotional images may be more useful if they reflect a
broad range of melanomas, particularly at earlier stages.
Second, images may be enhanced by written descrip-
tions of early changes, and patients’ narratives to encou-
rage people to develop personal meaning from
knowledge (see DIPEx Health Experiences Research
Group, http://www.primarycare.ox.ac.uk/research/dipex/).
Third, promoting knowledge about ‘normal’ vs ‘abnormal’
moles may be helpful, as well as challenging incorrect
beliefs such as a mole needing to become lumpy or painful
before it may be considered ‘serious’.S u c hk n o w l e d g e
could be promoted alongside celebrity accounts as the lay
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media. Finally, future awareness campaigns could be tar-
g e t e da tt h eh i g h e rr i s kg r o u p s ,s u c ha se l d e r l ym e no r
people living alone, and they could promote the responsi-
bility of family and friends in appraising changes in moles
and reducing delays in seeking help.
Conclusions
This study has identified factors which influence patient
understanding of moles and skin cancer, and that can
trigger or act as barriers to seeking help for suspicious
skin lesions in primary care. Skin lesions are often felt
to be trivial, and changes may not signify possible skin
cancer. Further research relating to patient understand-
ing of information and images of moles and melanomas
could improve appraisal delay, and contribute to the
current national strategy to improve patient awareness
and earlier diagnosis of cancer.
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